Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • hbt
    Member
    • Jan 2011
    • 20

    RIN vs Volume?

    I have a set of RNA samples prepared for RNAseq, however the RIN values and total volume on a few of the samples are less than ideal (<7.0 RIN and ~1.5ug total RNA) per sample

    I have now produced a second set of samples (direct biological repeat) with much better RIN values (~8.6) but still low volume of total RNA.

    My question is whether I would get a better set of results by combining the two samples, thereby reducing the RIN value to and average of the two samples but providing the sequencing centre with a much greater volume of RNA to library prep from? (and presumable reducing the number of duplicates). Or do I just have the second set of samples sequenced as they are the best quality samples I have available?

    In other words, which has a greater affect on the quality, coverage level and level of duplicates of the dataset? RIN value or total volume?

    The first set of samples also had some poor 260/230 ratio values, does this have much affect on the RNAseq chemistry and could it compromise the quality of the results further?

    The samples are to sequenced (single end 50bp) on 1/3 of an illumina Hiseq2000 lane each, following RiboMinus treatment

    any thoughts would be greatly appreciated

    Thank you
  • hbt
    Member
    • Jan 2011
    • 20

    #2
    Sorry, have re-posted in correct forum (Sample Prep / Library Generation)

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
      by SEQadmin2


      Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

      The systematic characterization of the human proteome has
      ...
      07-20-2026, 11:48 AM
    • SEQadmin2
      Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
      by SEQadmin2



      Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
      ...
      07-09-2026, 11:10 AM
    • SEQadmin2
      Cancer Drug Resistance: The Lingering Barrier to Rising Survival
      by SEQadmin2



      Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

      There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
      07-08-2026, 05:17 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, Today, 12:17 PM
    0 responses
    10 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, Yesterday, 11:41 AM
    0 responses
    11 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-20-2026, 11:10 AM
    0 responses
    23 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-13-2026, 10:26 AM
    0 responses
    37 views
    0 reactions
    Last Post SEQadmin2  
    Working...